article thumbnail

Europe’s pharmaceutical packaging market to value over $35bn by 2028

European Pharmaceutical Review

Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent in 2022. percent in 2022. Having been valued at $27.04

article thumbnail

FDA Approvals: September 2022 Recap

Digital Pharmacist

When it comes to innovation in the development of new drugs and therapeutic biological products in the pharmaceutical industry, the United States Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research (CDER) is a key supporter of the pharmaceutical industry. . Date of Approval: 9/30/2022.

FDA 75
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Eli Lilly achieving significant gains in obesity results

Pharmaceutical Technology

Eli Lilly has achieved significant gains in the past quarter, leading to it becoming the most valuable pharmaceutical company in the world, with a market cap of $420bn, surpassing Johnson & Johnson. Lilly’s blockbuster therapy to tackle the global obesity pandemic will undoubtedly gain widespread adoption by patients and providers.

article thumbnail

Semaglutide weight loss injection launched in UK

European Pharmaceutical Review

The pharmaceutical company stated it believed that the launch of Wegovy will help provide an additional option to support people living with obesity in the UK. It was in February 2022 that NICE recommended the obesity treatment in its draft guidance.

article thumbnail

Parallel import of medicinal products: regulatory update

European Pharmaceutical Review

This concerns the quantity of the medicinal product in the packaging, ie, the increase or decrease in the number of units of the product in the outer packaging according to local demands and its labelling, including the leaflet, which should be in the language of the country into which the product is imported.

article thumbnail

AI Retrofit: Tackling Challenges with Cutting-Edge Technologies

ISPE

Fri, 10/28/2022 - 10:39. November / December 2022. 1 November 2022. This artificial intelligence (AI) retrofit project was a unique approach to implementing AI technology in a pharmaceutical environment within three months. Two factors improved significantly: the accuracy of the AI model and the labeling process.

article thumbnail

Unmet needs in the obesity market

Pharmaceutical Technology

Many of the GLP-1RAs are used off-label and are mainly indicated for patients with type 2 diabetes (T2D). Despite the anticipated arrival of novel therapies to treat obesity in the next ten years, GlobalData forecasts that major opportunities will remain for pharmaceutical companies to develop drugs for obesity that are longer acting.